Nanovaccine Study Achieves High Immune Response
Mar 14 2021 Read 605 Times
Scientists at the Warsaw University of Technology are working on a nanovaccine based on recombinant SARS-CoV-2 virus proteins covalently bound to biodegradable iron oxide nanoparticles (IONPs). Researchers from the Faculty of Chemical and Process Engineering and the Centre for Advanced Materials and Technologies along with a team of immunologists, are aiming to produce a vaccine that is simple and inexpensive to manufacture. They also intend to propose a method of fast development and production of vaccines against mutant forms of the virus or new viruses and bacteria that may be identified in the future.